The University of Chicago Header Logo

The majority of CD1d-sulfatide-specific T cells in human blood use a semiinvariant Vd1 TCR.

The majority of CD1d-sulfatide-specific T cells in human blood use a semiinvariant Vd1 TCR. Eur J Immunol. 2012 Sep; 42(9):2505-10.

View in: PubMed